Panel Discussion: Drug Development and Approval

Description: A panel discussion on recent developments in clinical trials and the important role of trial participants in the process of developing and testing new treatments for Alzheimer’s disease
Runtime: 00:46:02

Speaker: Laurie M. Ryan, PhD
Speaker title: Program Director, Alzheimer’s Disease Clinical Trials
Speaker organization: National Institute on Aging

Speaker: Billy Dunn, MD
Speaker title: Director, Office of Neuroscience
Speaker organization: United States Food and Drug Administration

Speaker: Rachel J. Schindler, MD
Speaker title: Vice President, Clinical Disease Area Expert, Neurosciences
Speaker organization: Pfizer

Speaker: Johan Luthman, MD, PhD
Speaker title: Vice President, Neuroscience Clinical Development
Speaker organization: Eisai Neurology Business Group

Event: 2016 DIAD Family Conference: Too Young to Forget
Location: Toronto, Ontario, Canada
Year: 2016

Search tags: APOE4, DIAN-TU, clinical trials, drug development, tau tangles, antibodies, risk and safety, drugability, data sharing, biomarkers, anti-amyloid approaches, non-pharmacological interventions, recruitment, advocacy, regulation